Koyuan Pharmaceutical: Shareholder Wen Zehong plans to reduce his stake in the company by no more than 3%.

Koyuan Pharmaceutical announced that major shareholder Wen Zehong plans to reduce its holdings of the company's shares by no more than 3,248,700 shares, representing 3.00% of the total share capital. Among these, the reduction through centralized competitive trading will not exceed 1,082,900 shares, accounting for 1.00% of the total share capital; the reduction through bulk trading will not exceed 2,165,800 shares, accounting for 2.00% of the total share capital. The reduction period will be within three months after fifteen trading days from the date of the announcement. The reduction price will be determined based on market price, and will not be lower than the issue price.